Outcomes of children with proliferative lupus nephritis: The role of protocol renal biopsy

Pediatric Nephrology

Volumn 22, Issue 7, 2007, Pages 981-986

  Askenazi, David ^a   Myones, Barry ^b   Kamdar, Ankur ^b   Warren, Robert ^b   Perez, Maria ^b   Guzman, Marietta ^b   Minta, Anna ^b   Hicks, M John ^c   Kale, Arundhati ^b  

^a University of Alabama at Birmingham   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclophosphamide; Lupus nephritis; Outcome; Proliferative; Protocol biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTION; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

BIOPSY; CHILD; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; KIDNEY; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; NEUTROPHILS; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34250014479     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0447-9     Document Type: Article

References (24)

1. Austin HA 3rd, Klippel JH, Balow JE, le Richie NG, Steinberg AD, Poltz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619
2. Donadio JV Jr, Holley KE, Ferguson RH, Ilstrup DM (1978) Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299:1151-1155
3. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241-250
4. Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945-950
5. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A (1996) Lupus nephritis in children: A longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924-929
6. Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, Ognjanovic M, Minic A, Stajic N (2004) Lupus nephritis in childhood: A review of 53 patients followed at a single center. Pediatr Nephrol 19:36-44
7. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29:2635-2642
8. McCurdy DK, Lehman TJ, Bernstein B, Hanson V, King KK, Nadorra R, Landing BH (1992) Lupus nephritis: Prognostic factors in children. Pediatrics 89:240-246
9. Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158-166
10. Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children' a review of 167 patients. Pediatrics 94:335-340
11. Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, Perfumo F (2002) Childhood-onset lupus nephritis: A single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol 15:123-129
12. De Bandt M, Goycochea MV, Meyer O, Delahousse M, Palazzo E, M'Bappe P, Kahn MF (1994) Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations. Ann Med Interne (Paris) 145:75-87
13. Gladman DD, Urowitz MB, Cole E, Ritchie S, Chang CH, Churg J (1989) Kidney biopsy in SLE. I. A clinical-morphologic evaluation. Q J Med 73:1125-1133
14. Pillemer SR, Austin HA 3rd, Tsokos GC, Balow JE (1988) Lupus nephritis: association between serology and renal biopsy measures. J Rheumatol 15:284-288
15. Gunnarsson I, Sundelin B, Heimburger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH (2002) Repeated renal biopsy in proliferative lupus nephritis-predictive role of serum C1q and albuminuria. J Rheumatol 29:693-699
16. Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP, Bariety J (2001) Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 59:304-316
17. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
18. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarin M (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: A study of 87 patients and review of the literature. Q J Med 72:779-833
19. Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ (1992) Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116:114-123
20. Moroni G, Pasquali S, Quaglini S, Banfi G, Casanova S, Maccario M, Zucchelli P, Ponticelli C (1999) Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 34:530-539
21. Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C (1996) "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50:2047-2053
22. Ponticelli C, Moroni G (1998) Flares in lupus nephritis: Incidence, impact on renal survival and management. Lupus 7:635-638
23. Lenz O, Fornoni A, Contreras G (2006) New directions in the management of severe lupus nephritis. Minerva Urol Nefrol 58:29-38
24. Robak E, Sysa-Jedrzejowska A, Wozniacka A (2005) Progress and perspectives in the treatment of systemic lupus erythematosus. Przegl Lek 62:894-899